Endoscopic instillation of fungicide to treat aspergilloma

Efficacy of Radial Endobronchial Ultrasound (R-EBUS) guided transbronchial cryobiopsy for peripheral pulmonary lesions (PPL...s): A systematic review and meta-analysis.

Pulmonology·2021

TB infection and BCG vaccination: are we protected from COVID-19?

Public health·2020

Novel use of bioelectric impedence technique to detect alterations in body composition in advanced small cell lung cancer.

Indian journal of cancer·2018

Dilemma of diagnosing thoracic sarcoidosis in tuberculosis endemic regions: An imaging-based approach. Part 1.

The Indian journal of radiology & imaging·2018

Dilemma of diagnosing thoracic sarcoidosis in tuberculosis-endemic regions: An imaging-based approach. Part 2.

The Indian journal of radiology & imaging·2018

Circulating genotypes of Pneumocystis jirovecii and its clinical correlation in patients from a single tertiary center in India.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2017

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Lancet (London, England)·2026

Growth-Associated Reorganization of Gill and Skin-Mucus Microbiota in Cultured Decapterus maruadsi: Contrasting Occurrence-Abundance Patterns.

Veterinary sciences·2026

Time-Series Multi-Omics Reveal Metabolic Reprogramming, Oxidative Stress and Programmed Cell Death in M. bovis-Infected Bovine Mammary Epithelial Cells.

Microorganisms·2026

Mycobacteriophages: An Integrated Platform for Rapid Diagnosis and Targeted Therapy of Tuberculosis Infection.

Microorganisms·2026

Genotype × Isolate Interactions for Tan Spot Resistance Screening in Mungbean.

Plants (Basel, Switzerland)·2026

Mannose-Functionalized Polymeric Micelles Target CD206-Expressing Macrophages Within Human Tuberculosis Granulomas and Improve Isoniazid Delivery.

Pharmaceutics·2026

LC-MS/MS Quantification of the Anti-Tuberculosis Macrolide Arenicolide A in Rat Plasma: Method Validation and Pharmacokinetic Application.

Pharmaceutics·2026

Related Experiment Videos

Endoscopic instillation of fungicide to treat aspergilloma

Related Concept Videos

Efficacy of Radial Endobronchial Ultrasound (R-EBUS) guided transbronchial cryobiopsy for peripheral pulmonary lesions (PPL...s): A systematic review and meta-analysis.

TB infection and BCG vaccination: are we protected from COVID-19?

Novel use of bioelectric impedence technique to detect alterations in body composition in advanced small cell lung cancer.

Dilemma of diagnosing thoracic sarcoidosis in tuberculosis endemic regions: An imaging-based approach. Part 1.

Dilemma of diagnosing thoracic sarcoidosis in tuberculosis-endemic regions: An imaging-based approach. Part 2.

Circulating genotypes of Pneumocystis jirovecii and its clinical correlation in patients from a single tertiary center in India.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Growth-Associated Reorganization of Gill and Skin-Mucus Microbiota in Cultured Decapterus maruadsi: Contrasting Occurrence-Abundance Patterns.

Time-Series Multi-Omics Reveal Metabolic Reprogramming, Oxidative Stress and Programmed Cell Death in M. bovis-Infected Bovine Mammary Epithelial Cells.

Mycobacteriophages: An Integrated Platform for Rapid Diagnosis and Targeted Therapy of Tuberculosis Infection.

Genotype × Isolate Interactions for Tan Spot Resistance Screening in Mungbean.

Mannose-Functionalized Polymeric Micelles Target CD206-Expressing Macrophages Within Human Tuberculosis Granulomas and Improve Isoniazid Delivery.

LC-MS/MS Quantification of the Anti-Tuberculosis Macrolide Arenicolide A in Rat Plasma: Method Validation and Pharmacokinetic Application.

Related Experiment Videos

Endoscopic instillation of fungicide to treat aspergilloma

Related Concept Videos

Related Articles